HomeInsightsStock Comparison

Dr Agarwals Eye Hospital Ltd vs Lotus Eye Hospital Institute Ltd Stock Comparison

Dr Agarwals Eye Hospital Ltd vs Lotus Eye Hospital Institute Ltd Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

  • The Latest Trading Price of Dr Agarwals Eye Hospital Ltd is ₹ 5280 as of 30 Oct 15:30 . The P/E Ratio of Dr Agarwals Eye Hospital Ltd changed from 14.3 on March 2022 to 32.4 on March 2026 . This represents a CAGR of 17.77% over 5 yearsThe P/E Ratio of Lotus Eye Hospital & Institute Ltd changed from 55.9 on March 2021 to 2533 on March 2026 . This represents a CAGR of 88.83% over 6 years The Market Cap of Dr Agarwals Eye Hospital Ltd changed from ₹ 147.16 crore on March 2021 to ₹ 2271 crore on March 2026 . This represents a CAGR of 57.79% over 6 yearsThe Market Cap of Lotus Eye Hospital & Institute Ltd changed from ₹ 87.14 crore on March 2021 to ₹ 210.77 crore on March 2026 . This represents a CAGR of 15.86% over 6 years The revenue of Dr Agarwals Eye Hospital Ltd for the Jun '26 is ₹ 144.93 crore as compare to the Mar '26 revenue of ₹ 121.58 crore. This represent the growth of 19.21% The revenue of Lotus Eye Hospital & Institute Ltd for the Jun '26 is ₹ 17.27 crore as compare to the Mar '26 revenue of ₹ 14.09 crore. This represent the growth of 22.57% The ebitda of Dr Agarwals Eye Hospital Ltd for the Jun '26 is ₹ 45.22 crore as compare to the Mar '26 ebitda of ₹ 35.3 crore. This represent the growth of 28.1% The ebitda of Lotus Eye Hospital & Institute Ltd for the Jun '26 is ₹ 3.15 crore as compare to the Mar '26 ebitda of ₹ 0.95 crore. This represent the growth of 231.58% The net profit of Dr Agarwals Eye Hospital Ltd changed from ₹ 14.11 crore to ₹ 23.38 crore over 9 quarters. This represents a CAGR of 25.16% The net profit of Lotus Eye Hospital & Institute Ltd changed from ₹ 0.62 crore to ₹ 0.61 crore over 9 quarters. This represents a CAGR of -0.72% The Dividend Payout of Dr Agarwals Eye Hospital Ltd changed from 5.85 % on March 2022 to 4.82 % on March 2026 . This represents a CAGR of -3.80% over 5 yearsThe Dividend Payout of Lotus Eye Hospital & Institute Ltd changed from 66.24 % on March 2021 to 0 % on March 2026 . This represents a CAGR of -100.00% over 6 years .

About Dr Agarwals Eye Hospital Ltd

  • Founded in 1957, Dr. Agarwal's Eye Hospital Limited was incorporated on April 22, 1994.
  • The Hospital is a leading chain of eye hospitals with predominant presence in Tamil Nadu.
  • Company has been a pioneer and leader into the Indian Ophthalmology market in the eye care division.
  • It offers comprehensive services in the eye-care segment including Cataract, Glaucoma, Laser Correction, Cornea and Refractive, Retina, and Squint among others.
  • It has presence in Tamil Nadu, Kerala and Rajasthan states. The Company is primarily engaged in running, owning and managing eye care hospitals, opticals, pharmacies, etc. and related services.

About Lotus Eye Hospital & Institute Ltd

  • Lotus Eye Hospital & Institute Limited, a trust hospital, was originally incorporated as 'Kalaivani Health Centre Pvt.
  • Limited' on 14 March, 1997.
  • The name of the Company was changed to 'Lotus Eye Care Hospital Pvt.
  • Limited' on 23 January, 2006 and later on, the Company was converted into a Public Limited Company on October 16, 2007 and subsequently, the name was changed to Lotus Eye Hospital & Institute Limited on April 12, 2013. Founded in 1990 by renowned ophthalmic surgeon late Dr. S.K. Sundaramoorthy, the Company operates 9 Eye Care centers in Tamil Nadu and Kerala: 7 Centres in Tamil Nadu: Coimbatore (Peelamedu, RS puramand Saravanampatti), Salem , Tirupur Mettupalayam and Karur. 2 Centresin Kerala: Kochi and Mulanthuruthy. Lotus Eye Care Hospital is the state of art eye care hospital group functioning in South India with specialization in super-specialty service related to eye care.

FAQs for the comparison of Dr Agarwals Eye Hospital Ltd and Lotus Eye Hospital & Institute Ltd

Which company has a larger market capitalization, Dr Agarwals Eye Hospital Ltd or Lotus Eye Hospital & Institute Ltd?

Market cap of Dr Agarwals Eye Hospital Ltd is 2,551 Cr while Market cap of Lotus Eye Hospital & Institute Ltd is 221 Cr

What are the key factors driving the stock performance of Dr Agarwals Eye Hospital Ltd and Lotus Eye Hospital & Institute Ltd?

The stock performance of Dr Agarwals Eye Hospital Ltd and Lotus Eye Hospital & Institute Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Agarwals Eye Hospital Ltd and Lotus Eye Hospital & Institute Ltd?

As of November 1, 2026, the Dr Agarwals Eye Hospital Ltd stock price is INR ₹5280.15. On the other hand, Lotus Eye Hospital & Institute Ltd stock price is INR ₹106.5.

How do dividend payouts of Dr Agarwals Eye Hospital Ltd and Lotus Eye Hospital & Institute Ltd compare?

To compare the dividend payouts of Dr Agarwals Eye Hospital Ltd and Lotus Eye Hospital & Institute Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions